H. Stewart Parker has over 30 years of experience in the biotechnology industry. She previously served as the Chief Executive Officer of the Infectious Disease Research Institute, or IDRI, a nonprofit research organization focused on the development of products for the diagnosis, prevention, and treatment of neglected diseases from March 2011 to January 2014. Prior to IDRI, Ms. Parker managed the formation of Targeted Genetics Corporation, as a wholly owned subsidiary of Immunex Corporation, and served as its President and Chief Executive Officer and as a Director from its spinout from Immunex Corporation in 1992 to November 2008. She served in various capacities at Immunex Corporation from August 1981 through December 1991, most recently as Vice President, Corporate Development. Ms. Parker currently serves on the Board of Directors of Sangamo Therapeutics since June 2014 and Armata Pharmaceuticals, Inc., since May 2019. She has served on the Board of Directors and the Executive Committee of BIO, the primary trade organization for the biotechnology industry. Ms. Parker has also served as a Director of Neose Technologies, Inc., from May 2005 to January 2009. Ms. Parker received her B.A. and M.B.A. degrees from the University of Washington.
